Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting

Added 60 days ago (24.07.2021)
Authors: Sara Kolehmainen; Tero Ylisaukko-oja; Jari Jokelainen; Mirkka Koivusalo; T. Sakari Jokiranta; Taina Sipponen
Read article